CALC
Price
$3.19
Change
-$0.02 (-0.62%)
Updated
Oct 20, 04:58 PM (EDT)
Capitalization
44.85M
Intraday Buy/Sell Signals
OBIO
Price
$3.90
Change
+$0.58 (+17.47%)
Updated
Oct 20, 04:59 PM (EDT)
Capitalization
179.13M
Intraday Buy/Sell Signals
Interact to see
Advertisement

CALC vs OBIO

Header iconCALC vs OBIO Comparison
Open Charts CALC vs OBIOBanner chart's image
CalciMedica
Price$3.19
Change-$0.02 (-0.62%)
Volume$100
Capitalization44.85M
Orchestra BioMed Holdings
Price$3.90
Change+$0.58 (+17.47%)
Volume$661
Capitalization179.13M
CALC vs OBIO Comparison Chart in %
CALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CALC vs. OBIO commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CALC is a Hold and OBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 21, 2025
Stock price -- (CALC: $3.21 vs. OBIO: $3.32)
Brand notoriety: CALC and OBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CALC: 39% vs. OBIO: 115%
Market capitalization -- CALC: $44.85M vs. OBIO: $179.13M
CALC [@Biotechnology] is valued at $44.85M. OBIO’s [@Biotechnology] market capitalization is $179.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CALC’s FA Score shows that 1 FA rating(s) are green whileOBIO’s FA Score has 0 green FA rating(s).

  • CALC’s FA Score: 1 green, 4 red.
  • OBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, CALC is a better buy in the long-term than OBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CALC’s TA Score shows that 5 TA indicator(s) are bullish while OBIO’s TA Score has 5 bullish TA indicator(s).

  • CALC’s TA Score: 5 bullish, 4 bearish.
  • OBIO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CALC is a better buy in the short-term than OBIO.

Price Growth

CALC (@Biotechnology) experienced а +1.42% price change this week, while OBIO (@Biotechnology) price change was +5.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.76%. For the same industry, the average monthly price growth was +18.12%, and the average quarterly price growth was +72.90%.

Industries' Descriptions

@Biotechnology (+4.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OBIO($179M) has a higher market cap than CALC($44.9M). CALC YTD gains are higher at: -9.322 vs. OBIO (-17.000). CALC has higher annual earnings (EBITDA): -30.55M vs. OBIO (-70.94M). OBIO has more cash in the bank: 33.9M vs. CALC (18M). CALC has less debt than OBIO: CALC (8.5M) vs OBIO (16.4M). OBIO has higher revenues than CALC: OBIO (2.94M) vs CALC (0).
CALCOBIOCALC / OBIO
Capitalization44.9M179M25%
EBITDA-30.55M-70.94M43%
Gain YTD-9.322-17.00055%
P/E Ratio0.30N/A-
Revenue02.94M-
Total Cash18M33.9M53%
Total Debt8.5M16.4M52%
TECHNICAL ANALYSIS
Technical Analysis
CALCOBIO
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
55%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
71%
Momentum
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
52%
MACD
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
48%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
51%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
52%
Advances
ODDS (%)
Bullish Trend 14 days ago
78%
Bullish Trend 5 days ago
63%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
60%
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
CALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBHC36.370.76
+2.13%
NATIONAL BANK HOLDINGS Corp
AZN84.690.86
+1.03%
AstraZeneca PLC
MGLD1.01-0.01
-0.76%
Marygold Companies (The)
NAKA0.72-0.04
-4.89%
Kindly MD Inc
LIF87.60-4.52
-4.91%
Life360 Inc Common Stock

CALC and

Correlation & Price change

A.I.dvisor tells us that CALC and OBIO have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CALC and OBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CALC
1D Price
Change %
CALC100%
-1.23%
OBIO - CALC
33%
Poorly correlated
-9.78%
ABOS - CALC
27%
Poorly correlated
-4.69%
ALDX - CALC
26%
Poorly correlated
-2.41%
VTYX - CALC
26%
Poorly correlated
-2.00%
LITS - CALC
26%
Poorly correlated
+1.62%
More

OBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, OBIO has been loosely correlated with RXRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if OBIO jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OBIO
1D Price
Change %
OBIO100%
-9.78%
RXRX - OBIO
39%
Loosely correlated
-7.86%
XBIT - OBIO
39%
Loosely correlated
N/A
CRIS - OBIO
36%
Loosely correlated
-1.28%
OCUL - OBIO
36%
Loosely correlated
-2.95%
IPSC - OBIO
36%
Loosely correlated
-2.60%
More